Development of fecal microbial diagnostic marker sets of colorectal cancer using natural language processing method.

Journal: The International journal of biological markers
PMID:

Abstract

BACKGROUND: Cancer screening and early detection greatly increase the chances of successful treatment. However, most cancer types lack effective early screening biomarkers. In recent years, natural language processing (NLP)-based text-mining methods have proven effective in searching the scientific literature and identifying promising associations between potential biomarkers and disease, but unfortunately few are widely used.

Authors

  • Houcong Liu
    Research Center for Clinical and Translational Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital, and the 6th Affiliated Hospital of Shenzhen University Medical School, Shenzhen, Guangdong, China.
  • Changpu Song
    Guangdong Jiyin Biotech Co. Ltd, Shenzhen, Guangdong, China.
  • Jidong Wang
    School of Information Science and Engineering, Northeastern University, Shenyang 110819, China. Electronic address: kfwjd@ncwu.edu.cn.
  • Zhufang Chen
    Research Center for Clinical and Translational Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital, and the 6th Affiliated Hospital of Shenzhen University Medical School, Shenzhen, Guangdong, China.
  • Xiaohong Zhang
    College of Electronics and Information, Hangzhou Dianzi University, Hangzhou, 311300, PR China.
  • Hekai Zhou
    Research Center for Clinical and Translational Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital, and the 6th Affiliated Hospital of Shenzhen University Medical School, Shenzhen, Guangdong, China.
  • Linhong Yao
    Research Center for Clinical and Translational Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital, and the 6th Affiliated Hospital of Shenzhen University Medical School, Shenzhen, Guangdong, China.
  • Dan Chen
    Department of Information Engineering, Southwest Jiaotong University Hope College, Chengdu, Sichuan, China.
  • Wenhao Gu
    Guangdong Jiyin Biotech Co. Ltd, Shenzhen, Guangdong, China.
  • Rui-Kun Huang
    Guangdong Jiyin Biotech Co. Ltd, Shenzhen, Guangdong, China.
  • Bing-Kun Huang
    Guangdong Jiyin Biotech Co. Ltd, Shenzhen, Guangdong, China.
  • Bo-Wei Han
    Guangdong Jiyin Biotech Co. Ltd, Shenzhen, Guangdong, China.
  • Jihui Du
    Research Center for Clinical and Translational Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital, and the 6th Affiliated Hospital of Shenzhen University Medical School, Shenzhen, Guangdong, China.